News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes Michael O'Riordan April 25, 2016
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011
News Daily News No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients L.A. McKeown August 19, 2011
News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011